1. Calpain-Mediated Mitochondrial Damage: An Emerging Mechanism Contributing to Cardiac Disease
    Mengxiao Zhang et al, 2021, Cells CrossRef
  2. Prolyl Hydroxylase Inhibitors: a New Opportunity in Renal and Myocardial Protection
    Juan Antonio Requena-Ibáñez et al, 2021, Cardiovasc Drugs Ther CrossRef
  3. The Cell Protective Effect of Adenine on Hypoxia–Reoxygenation Injury through PPAR Delta Activation
    Jyh-Gang Leu et al, 2021, Life CrossRef
  4. The Interplay of Hypoxia Signaling on Mitochondrial Dysfunction and Inflammation in Cardiovascular Diseases and Cancer: From Molecular Mechanisms to Therapeutic Approaches
    Esmaa Bouhamida et al, 2022, Biology CrossRef
  5. Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
    Juan Salazar et al, 2022, IJMS CrossRef
  6. Ozone preconditioning protects rabbit heart against global ischemia-reperfusion injury in vitro by up-regulating HIF-1α
    Rui Wang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  7. Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI)
    Marco Piccoli et al, 2022, IJMS CrossRef
  8. Albendazole ameliorates inflammatory response in a rat model of acute mesenteric ischemia reperfusion injury
    Abolfazl Badripour et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  9. Role of Oxidative Stress in Cardiac Dysfunction and Subcellular Defects Due to Ischemia-Reperfusion Injury
    Naranjan S. Dhalla et al, 2022, Biomedicines CrossRef
  10. The Innate Immune System and Fever under Redox Control: A Narrative Review
    Szőke Henrik et al, 2022, CMC CrossRef
  11. Interleukin 32 participates in cardiomyocyte‑induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway
    Yuanyuan Li et al, 2022, Exp Ther Med CrossRef
  12. Quercetin improves pancreatic cancer chemo‐sensitivity by regulating oxidative‐inflammatory networks
    Yaoyuan Hu et al, 2022, Journal of Food Biochemistry CrossRef
  13. Effects of hypoxia and reoxygenation on mitochondrial functions and transcriptional profiles of isolated brain and muscle porcine cells
    Linda Adzigbli et al, 2022, Sci Rep CrossRef
  14. Research progress on effects of traditional Chinese medicine on myocardial ischemia–reperfusion injury: A review
    Na Xing et al, 2022, Front. Pharmacol. CrossRef
  15. Prostaglandin E2 mediates the late phase of ischemic preconditioning in the heart via its receptor subtype EP4
    Takayasu Kanno et al, 2022, Heart Vessels CrossRef
  16. Molecular characterisation of coding regions OF HIF-1a gene in Vechur cattle by cDNA sequencing
    P.R. Ramya et al, 2022, Heliyon CrossRef
  17. Research Progress of Chinese Medicine in the Treatment of Myocardial Ischemia–Reperfusion Injury
    Li Dong et al, 2023, Am. J. Chin. Med. CrossRef
  18. Exploring Myocardial Ischemia-Reperfusion Injury Mechanism of Cinnamon by Network Pharmacology, Molecular Docking, and Experiment Validation
    Tao Xue et al, 2023, Computational and Mathematical Methods in Medicine CrossRef
  19. Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications
    Antonella Galeone et al, 2023, IJMS CrossRef
  20. Relationship between ferroptosis and mitophagy in cardiac ischemia reperfusion injury: a mini-review
    Cuihua Liu et al, 2023 CrossRef
  21. HIF‐1α‐induced upregulated miR‐322 forms a feedback loop by targeting Smurf2 and Smad7 to activate Smad3/β‐catenin/HIF‐1α, thereby improving myocardial ischemia‐reperfusion injury
    Wei Dong et al, 2023, Cell Biology International CrossRef
  22. Hydrogen sulfide plays an important role by regulating endoplasmic reticulum stress in myocardial diseases
    Huijie Zhao et al, 2023, Front. Pharmacol. CrossRef
  23. The relationship between CD4+ T cell glycolysis and their functions
    Siyi Liu et al, 2023, Trends in Endocrinology & Metabolism CrossRef
  24. Molecular Characterisation of Coding Regions of HIF-1a Gene in Vechur Cattle by Cdna Sequencing
    Ramya P.R. et al, 2022, SSRN Journal CrossRef
  25. Mesenchymal Stem Cells for Treating Alzheimer’s Disease: Cell Therapy and Chemical Reagent Pretreatment
    Kexin Zhang et al, 2023, JAD CrossRef
  26. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury
    Nan Xing et al, 2023, Journal of Ethnopharmacology CrossRef
  27. Association of Long Noncoding RNA Expression Signatures with Stress-Induced Myocardial Perfusion Defects
    Yu-Chieh Chang et al, 2023, Biomolecules CrossRef
  28. The Role of P53 in Myocardial Ischemia-Reperfusion Injury
    Xi-zi Zhu et al, 2023, Cardiovasc Drugs Ther CrossRef
  29. Identification of alternative splicing and RNA-binding proteins involved in myocardial ischemia–reperfusion injury
    Li Feng et al, 2023, Genome CrossRef
  30. Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1α/SLC7A11/GPX4 Signaling Pathway
    Chaowen Ge et al, 2023, Nutrients CrossRef
  31. Screening of renal clear cell carcinoma prognostic marker genes based on TCGA and GTEx chip data and construction of transcription factor-related regulatory networks
    Wei Zhu et al, 2023, Heliyon CrossRef
  32. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics
    Lifang Yang et al, 2023, Trends in Pharmacological Sciences CrossRef
  33. Recent Advances of Using Exosomes as Diagnostic Markers and Targeting Carriers for Cardiovascular Disease
    Ni Li et al, 2023, Mol. Pharmaceutics CrossRef
  34. Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway
    Peng Zhang et al, 2023, J. of Cardiovasc. Trans. Res. CrossRef
  35. The signaling pathway of hypoxia inducible factor in regulating gut homeostasis
    Wei Liu et al, 2023, Front. Microbiol. CrossRef
  36. Muscone ameliorates myocardial ischemia‒reperfusion injury by promoting myocardial glycolysis
    Xin Gu et al, 2023, Heliyon CrossRef
  37. Huoxin Pill Reduces Myocardial Ischemia Reperfusion Injury in Rats via TLR4/NFκB/NLRP3 Signaling Pathway
    Ce Cao et al, 2023, Chin. J. Integr. Med. CrossRef
  38. The role and regulatory mechanism of HIF-1α in myocardial injury in rats undergoing cardiopulmonary bypass
    Mingxia Zhang et al, 2023, Acta Cardiologica CrossRef
  39. Ischemia–Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction
    R. G. Goncharov et al, 2023, Mol Biol CrossRef
  40. Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway
    Yue Han et al, 2023, BMC Complement Med Ther CrossRef
  41. Hypoxia-inducible factor-1: Regulatory mechanisms and drug therapy in myocardial infarction
    Jinyuan Pan et al, 2023, European Journal of Pharmacology CrossRef
  42. Hsa_circ_0081065 exacerbates IH-induced EndMT via regulating miR-665/HIF-1α signal axis and HIF-1α nuclear translocation
    Shan Jiang et al, 2024, Sci Rep CrossRef
  43. CircRbms1 fosters MST1 mRNA and protein levels to motivate myocardial ischaemia–reperfusion injury via autophagic status
    Qin Liu et al, 2024, ESC Heart Failure CrossRef
  44. Exploring the Interplay of Uric Acid and Advanced Oxidation Protein Products Following Myocardial Infarction
    Joanna Sikora et al, 2024, Applied Sciences CrossRef
  45. The Janus face of mitophagy in myocardial ischemia/reperfusion injury and recovery
    Jiaxin Deng et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  46. Electroacupuncture pretreatment mediates sympathetic nerves to alleviate myocardial ischemia–reperfusion injury via CRH neurons in the paraventricular nucleus of the hypothalamus
    Jie Zhou et al, 2024, Chin Med CrossRef
  47. Targeted drug delivery of engineered mesenchymal stem/stromal-cell-derived exosomes in cardiovascular disease: recent trends and future perspectives
    Jian-Liang Pang et al, 2024, Front. Bioeng. Biotechnol. CrossRef
  48. SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases
    Mateusz Sobczyk et al, 2024, Prosp. Pharm. Sc. CrossRef
  49. Bioinformatics integration reveals key genes associated with mitophagy in myocardial ischemia-reperfusion injury
    Zhian Chen et al, 2024, BMC Cardiovasc Disord CrossRef
  50. Ischemia-Reperfusion Injury: Molecular Mechanisms of Pathogenesis and Methods of Their Correction
    R. G. Goncharov et al, 2023, Molekulârnaâ biologiâ CrossRef
  51. Modulation of NLRP3 inflammasome-related-inflammation via RIPK1/RIPK3-DRP1 or HIF-1α Signaling by Phenothiazine in Hypothermic and Normothermic Neuroprotection after Acute Ischemic Stroke
    Qian Jiang et al, 2024, Redox Biology CrossRef
  52. Interplay between Hypoxia Inducible Factor-1 and mitochondria in cardiac diseases
    Jeanne Mialet-Perez et al, 2024, Free Radical Biology and Medicine CrossRef
  53. Hypoxic Inducible Factor Stabilization in Pericytes beyond Erythropoietin Production: The Good and the Bad
    Dario Troise et al, 2024, Antioxidants CrossRef
  54. Gallic acid pretreatment mitigates parathyroid ischemia–reperfusion injury through signaling pathway modulation
    Nianqiu Liu et al, 2024, Sci Rep CrossRef
  55. Management of ROS and Regulatory Cell Death in Myocardial Ischemia–Reperfusion Injury
    Ge Gong et al, 2024, Mol Biotechnol CrossRef
  56. Nucleotide depletion in hypoxia experimental models of mouse myocardial slices
    Magdalena A. Zabielska-Kaczorowska et al, 2024, Nucleosides, Nucleotides & Nucleic Acids CrossRef
  57. Leveraging Hypotension Prediction Index to Forecast LPS-Induced Acute Lung Injury and Inflammation in a Porcine Model: Exploring the Role of Hypoxia-Inducible Factor in Circulatory Shock
    Yuan-Ming Tsai et al, 2024, Biomedicines CrossRef
  58. Neuroprotective effects of GPR68 against cerebral ischemia-reperfusion injury via the NF-κB/Hif-1α pathway
    Xianglong Li et al, 2024, Brain Research Bulletin CrossRef
  59. Global Research Trends on Exosome in Cardiovascular Diseases: A Bibliometric-Based Visual Analysis
    Yunxiao Gu et al, 2024, VHRM CrossRef
  60. Hydrogen sulfide plays an important role by regulating microRNA in different ischemia–reperfusion injury
    Qi Zhang et al, 2024, Biochemical Pharmacology CrossRef
  61. The activation of the HIF-1α-VEGFA-Notch1 signaling pathway by Hydroxysafflor yellow A promotes angiogenesis and reduces myocardial ischemia–reperfusion injury
    Chaowen Ge et al, 2024, International Immunopharmacology CrossRef
  62. Valtrate Suppresses TNFSF14-Mediated Arrhythmia After Myocardial Ischemia–Reperfusion by Inducing N-linked Glycosylation of LTβR to Regulate MGA/MAX/c-Myc/Cx43
    Jing Zhang et al, 2024 CrossRef
  63. Network pharmacology mechanism exploration of forsythia in analgesic treatment of rheumatic arthritis
    Wen-Long Zhu et al, 2024, ND CrossRef
  64. Detection of heat transfer mechanism in biological systems and HIF-1 α inducing invasion of liver cancer cells in hypoxic environments by activating STAT3
    Xunyan Ouyang et al, 2024, Thermal Science and Engineering Progress CrossRef
  65. Ischemic Rescue Potential of Conditioned Medium Derived from Skeletal Muscle Cells-Seeded Electrospun Fiber-Coated Human Amniotic Membrane Scaffolds
    Hanis Nazihah Hasmad et al, 2024, IJMS CrossRef
  66. A brief overview of cardioprotective signaling
    Aleksandar Jovanović, 2024, Arhiv za farmaciju CrossRef
  67. HIF1α/SLC7A11 signaling attenuates 6-hydroxydopamine-induced ferroptosis in animal and cell models of Parkinson’s disease
    Xuejia Liu et al, 2024, Journal of Neurorestoratology CrossRef
  68. Baicalin plays a protective role by regulating ferroptosis in multiple diseases
    Shiyun Guo et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
  69. Vaspin inhibits ferroptosis: A new hope for treating myocardial ischemia–reperfusion injury
    Xuehong Lin et al, 2024, Cytojournal CrossRef
  70. Myocardial mRNA expression of interleukin-6 and hypoxia inducible factor-1α in neonates with congenital cardiac defects
    Nesrine Farhat et al, 2024, Mol Cell Pediatr CrossRef
  71. Assessing platelet-derived extracellular vesicles for potential as therapeutic targets in cardiovascular diseases
    Xin Xin et al, 2025, Expert Opinion on Therapeutic Targets CrossRef
  72. Hypoxia-inducible factor-1α inhibitor promotes non-alcoholic steatohepatitis development and increases hepatocellular lipid accumulation via TSKU upregulation
    Renli Zeng et al, 2025, Archives of Biochemistry and Biophysics CrossRef